Questo sito utilizza cookie per migliorare la tua esperienza. Approvando questo banner acconsenti all’uso dei cookie.

Per saperne di piu'

Approvo
COMPLICANZE
   
 Il principale studio sulle complicanze del diabete tipo 1 a cui l’ASRIS ha preso parte è lo studio Eurodiab Prospective Complication Study [link] che ha prodotto numerosi abstract di comunicazioni scientifiche e numerosi lavori relativi alla presenza delle complicanze e dei loro fattori di rischio al momento dell’iniziale screening e dopo 7 anni di follow up.  
 
 Eurodiab Prospective Complication Study

· Idzior-Walus B., Koivisto M., Mattock M. and the Eurodiab IDDM Complication Study Group: Cardiovascular Disease and Risk Factors in Insulin-dependent (Type 1) Diabetes in Europe. Diabetologia 35 (suppl.1), A 59, 1992.

· Stephenson J., Collins A., Viberti G., Navalesi R. and the Eurodiab IDDM Complication Study Group. University College London and 31 Centres in Europe: Renal Disease and Cardiovascular Risk Factors in Insulin-Dependent (Type 1) Diabetes in Europe. Diabetologia 35 (suppl.1), A 224 (abs.), 1992.

· Kerenyi ZS, Nunes-Corea J, Santeusanio F. and the Eurodiab IDDM Complication Study Group. University College London and 31 Centres in Europe: Acute Complications in Insulin-dependent (type 1) Diabetes. Diabetologia 35 (suppl. 1), A 183 (abs.), 1992.

· Toeller M., Klischan A., Heitkamp G., Schumacher W. and the Eurodiab IDDM Complications Study Group. Diabetes Research Institute, University of Düsseldorf, Germany and 31 Centres in Europe. Nutritional Intake in IDDM Patients. First Results from the Eurodiab IDDM Complication Study. Diabetologia 35 (suppl.1),A 164 (abs.), 1992.

· Testfaye S., Stevens L., Stephenson J., Ward JD. and the EURODIAB IDDM Complications Study Group: The prevalence of diabetic neuropathy and its relation to glycaemic control in insulin-dependent subjects in Europe. Diabetologia: 36 (suppl 1): A176, 1993.

· Mattlock M., Stephenson J., Collins A. and the EURODIAB IDDM Complications Study Group: Cardiovascular disease, cardiovascular risk factors and albuminuria in insulin-dependent diabetic patients in Europe. Diabetologia 36, (Suppl 1): A 205, 1993.

· Stephenson J., Fuller JH., Taskinen M-R., Ehnholm C. and the EURODIAB IDDM Complications Study Group: Relation of lipoproteins and apoproteins to albuminuria and cardiovascular disease in insulin-dependent diabetes. Diabetologia 36 (suppl 1): A206,1993.

· Chaturvedi N., Stephenson J., Fuller JH. and the EURODIAB IDDM Complications Study Group: Cigarette smoking and diabetic control and complications in insulin-dependent diabetes. Diabetologia 36 (suppl 1): A212, 1993.

· Pitei DL., Ward J., Testfaye S., Fuller J., The EURODIAB IDDM Complications Study Group: Frequency of Diabetic Neuropathy in Insulin-dependent (Type 1) Diabetes in Europe. Diabetic Med 10 (Suppl 1): S39 (abstract), 1993.

· Aldington SJ., Kohner EM., Klein R., Sjolie AK., The EURODIAB IDDM Complications Study Group: Photography and Assessment of Retinopathy in the EURODIAB IDDM Complications Study Group. Eur J Ophthamol 3: 151 (abstract), 1993.

· Sjolie AK., Stephenson J., Aldington S., Kohner E., The EURODIAB IDDM Complications Study Group: Prevalence of Retinopathy and Relation to Risk Factors in the EURODIAB IDDM Complications Study. Eur J Ophthamol 3:153 (Abstract), 1993.

· Stephenson J., Sjolie AK., Aldington SJ., Kohner EM.: Blood Pressure, Nephropathy and Retinopathy: EURODIAB IDDM Complications Study. Eur J Ophtamol 3: A 152, 1993.

· Toeller M., Klischan A., Schumacher W., Heitkamp G., Gries A. and the EURODIAB IDDM Complications Study Group: Ernährungsepidemiologische Untersuchungen bei Typ -1 Diabetikern in Europa. Diabetes und Stoffwechsel 2: A202 (Abstract), 1993.

· Roenningen KS., Halstensen TS., Undlien DE., Ploski R., Welsh K., Todd JA., Kockum I., de Vries N., Kimura A., Thorsby E., Green A. on behalf of the EURODIAB ACE Study Group: Correlation between Incidence of Childhood onset Diabetes and Frequency of High Risk HLA_Markers in European Populations, abstract presented at the 15th International Diabetes Federation Congress, Kobe poster 08A3OP0701, (Japan) 6-11 november 1994

· Fuller JH., Stevens L., Chaturvedi N., Stephenson J and the EURODIAB IDDM Complications Study Group: The Relationship between Blood Pressure and Risks for Ischaemic Heart Disease in Insulin-Dependent Diabetes - Diabetologia 37 (Suppl 1): A143 (abstract), 1994

· The EURODIAB IDDM Complications Study Group: Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study. Diabetologia; 37: 278-285, 1994

· Stephenson JM., Fuller JH., the EURODIAB IDDM Complications Study Group and the WHO Multinational Study of Vascular Disease in Diabetes Study Group: Microalbuminuria is not rare before five years of IDDM, J. Diabetic Complications; 8: 166-173, 1994

· Fuller JH., Stevens LK., Malia R., Greaves M. and the EURODIAB IDDM Complications Study Group: Relation to nephropathy of fibrinogen and Von Willebrand factor in insulin-dependent diabetes. Diabetologia 38 (Suppl.1): A214, 827 (abstract), 1995.

· Fuller JH., Stevens L. and the EURODIAB IDDM Complications Study Group: Relationship between glycaemic control, hypoglycaemia and frequency of complications in IDDM: modification by duration of disease. Diabetes 44 (Suppl.1): A584, 160A, 1995.

· Stevens LK., Fuller JH. and the EURODIAB IDDM Complications Study Group: The influence of retinopathy on the relationship between haemostatic factors and diabetic nephropathy. Abstract presented at the 30th Annual Meeting of the European Diabetes Epidemiology Study Group of the EASD, EDESG, Hindsgavl, Fyn, Denmark, 21-24 may 1995.

· Toeller M., Brämswig S., Heitkamp G., Milne R. and the EURODIAB IDDM Complications Study Group: Why are IDDM patients less successful than non-diabetics in following a lipid-lowering diet? - Abstract presented at the 30th Annual Meeting of the European Diabetes Epidemiology Study Group of the EASD, EDESG, Hindsgavl, Fyn, Denmark, 21-24 may 1995.

· Stephenson JM., Fuller JH., Viberti GC., Sjolie AK., Navalesi R. and the EURODIAB IDDM Complications Study Group: Blood pressure, retinopathy and urinary albuminuria excretion in insulin dependent diabetes: the EURODIAB IDDM Complications Study. Diabetologia 1995; 38: 599-603.

· Chaturvedi N., Stephenson JM., Fuller JH. and the EURODIAB IDDM Complications Study Group: The relationship between pregnancy and complications in insulin-dependent diabetes mellitus (IDDM). Diabetic Med 1995; 12: 494-499.

· Aldington SJ., Kohner EM., Meuer S., Klein R., Sjoelie AK. for the EURODIAB IDDM Complications Study Group: Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB IDDM Complications Study. Diabetologia 1995; 38: 437-444.

· Chaturvedi N, Stephenson JM, Fuller JH and the EURODIAB IDDM Complications Study Group: The relationship between smoking and microvascular complications in the EURODIAB IDDM Complications Study. Diabetes Care 1995; 18: 785-792.

· Lloyd CE., Stephenson J., Fuller JH., Orchard TJ.:A Comparison of Renal Disease across two Continents: The Epidemiology of Diabetes Complications Study Group and the EURODIAB Complications Study. Diabetes Care 1996; 19: 219-225.

· Koivisto VA, Stevens LK, Mattock M, Ebeling P, Muggeo M, Stephenson J, Idzior-Walus B. and the EURODIAB IDDM Complications Study Group: Cardiovascular disease and its risk factors in insulin-dependent diabetes in Europe. Diabetes Care 1996; 19: 689-697.

· Chaturvedi N, Stephenson JM, Fuller JH and the EURODIAB IDDM Complications Study Group: The relationship between socioeconomic status and diabetes control and complications in the EURODIAB IDDM Complications Study. Diabetes Care 1996; 19 (5): 423-430.

· Toeller M, Klischan A, Heitkamp G, Schumacher W, Milne R, Buyken A, Karamanos B, Gries FA and the EURODIAB IDDM Complications Study Group: Nutritional intake of 2868 IDDM patients from 30 centres in Europe. Diabetologia 1996; 39: 929-939.

· Stephenson JM, Kempler P, Cavallo-Perin P, Fuller JH and the EURODIAB IDDM Complications Study Group. Is autonomic neuropathy a risk factor for severe hypoglycaemia? The EURODIAB IDDM Complications Study. Diabetologia 1996; 39: 1372-1376.

· Tesfaye S, Stevens LK, Stephenson JM, Fuller JH, Plater M, Ward JD, Nuber A, Ionescu-Tirgoviste C, Pozza G and the EURODIAB IDDM Complications Study Group: The prevalence of diabetic neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia 1996; 39: 1377-1384.

· Sjolie AK, Stephenson J, Aldington S, Kohner E, Janka H, Stevens L, Fuller J and the EURODIAB IDDM Complications Study Group: Retinopathy and vision loss in insulin dependent diabetes in Europe. The EURODIAB IDDM Complications Study. Ophthalmology 1996; 104, 2: 252-260.

· Stephenson JM, Kempler P., Cavallo-Perin P., Fuller JH and the EURODIAB IDDM Complications Study Group: Is autonomic neuropathy a risk factor for severe hypoglicaemia? The EURODIAB IDDM Complications Study. Diabetologia 1996; 39: 1372-1376.

· Cathy E. Lloyd, Judith Stephenson, John H Fuller, and Trevor J. Orchard, on behalf of the Epidemilogy of Diabetes Complications Study, and the Eurodiab IDDM Complications Study Group. A comparison of renal disease across two continents: the Epidemiology of Diabetes Complications Study and the Eurodiab IDDM Complication Study. Diabetes Care 1996.

· Toeller M., Buyken A., Heitkamp G., Milne R., Klischan A., Gries FA. And the EURODIAB IDDM Complications Study Group: Repeatability of three-day dietary records in the EURODIAB IDDM Complications Study. European Journal of Clinical Nutrition 1997; 51: 74-80.

· Greaves M., Malia RG., Goodfellow K., Mattock M., Stevens LK., Stephenson JM., Fuller JH., and the EURODIAB IDDM Complications Study Group: Fibrinogen and von Willebrand factor in IDDM: relationship to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: the EURODIAB IDDM Complications study. Diabetologia 1997; 40: 698-705.

· Toeller M., Buyken A., Heitkamp G., Brämswig S., Mann J., Milne R., Gries FA., Keen H., and the EURODIAB IDDM Complications Study Group: Protein intake and urinary albumin excretion rates in the EURODIAB IDDM Complication Study. Diabetologia 1997; 40: 1219-1226.

· A. E. Buyken, M. Toeller, G. Heitkamp, F. Vitelli, P. Sthele, W. A. Scherbaum, J. H. Fuller and the Eurodiab IDDM Complications Study Group: Relation of fibre intake to HbA(1c) and the prevalence of severe Ketoacidosis and severe hypoglycaemia. Diabetologia 1998; 41: 882-890.

· G. Roglic, H.M. Colhoun, L.k. Stevens, H.H. Lemkes, C. Manes, J.H. Fuller, and the EURODIAB IDDM Complications Study Group: Parental History of Hypertension and Parental History of Diabetes and Microvascular Complications in Insulin-dependent Diabetes Mellitus: the EURODIAB IDDM Complications Study. Diabetic Medicine 1998; 15: 418-426.

· TJ Orchard, LK Stevens, KY-Z Forrest, and JH Fuller et alii: Cardiovvascular disease in insulin dependent diabetes mellitus: similar rates but different risk factors in the US compared with Europe. International Journal of Epidemiology 1998; 27: 976-983.

· F. Collado-Mesa, H. M. Colhount, L. K. Stevenst, J. Boavida, J. B. Ferriss, B. Karamanos, P. Kempler, G. Micheltt, G. Roglic, J.H. Fullert and the EURODIAB IDDM Complications Study Group. Prevance and management of hypertension in type 1 diabetes mellitus in Europe: the EURODIAB IDDM Complications Study. Diabetic Medicine 1999; 16:41-48

· M. Toeller, A. Buyken, G. Heitkamp, G. de Pergola, F. Giorgino, JH.Fuller and the EURODIAB IDDM Complication Study Group: Fibre intake, serum cholesterol levels and cardiovascolar disease in European individuals with type 1 diabetes. Diabetes Care 1999; 22 (suppl 2): B21-B28.

· The EURODIAB Prospective Complications Study (PCS) Group Royal Free and UCL Medical School, London, UK and 27 European Centres. Risk factors for progression of nephropathy in type 1 diabetic subjects in Europe. Diabetologia 1999; 42 (suppl. 1): A 71.

· A. E. Buyken, G. Hetkamp, M. Toeller and the EURODIAB Complications Study Group. Carbohydrate supplyng food groups differ in their relationto HBA1c in persons with type 1 diabetes. Diabetologia 1999; 42 (suppl. 1): A 214.

· B. Idzior-Wallus, L. Stevens, J. Sieradzki. J. H. Fuller, the EURODIAB IDDM Study Group. Serum lipid values and central obesity in type 1 diabetes – The EURODIAB IDDM Complications Study. Diabetologia 1999; 42 (suppl. 1): A 285.

· The EURODIAB Prospective Complications Study (PCS) Group. Incidence of retinopathy and risk factors in type 1 diabetes. Diabetologia 1999; 42 (suppl 1): A1-A330

· M. Toeller, A. E. Buyken, G. Heitkamp, W. A. Scherbaum, H. M. J. Krans, J. H. Fuller and the EURODIAB IDDM Complications Study Group:Associations of fat and cholesterol intake with serum lipid levels and cardiovascular disease: The EURODIAB IDDM Complications Study. Exp Clin Endocrinol Diabetes 1999; 107: 512-521.

· M. Toeller, A. E. Buyken, G. Heitkamp, G. Berg, W. A. Scherbaum, and the EURODIAB Complications Study Group: Prevalence of Chronic Complications, Metabolic Control and Nutritional Intake in Type 1 Diabetes: Comparison Between Different European Regions. Horm Metab Res 1999; 31:680-685.

· B. Karamanos, M. Porta, M.Songini, Z. Metelko, Z. Kerenyi, G. Tamas, R. Rottiers, L.K. Stevens, J.H.Fuller, and the EURODIAB IDDM Complications Study Group: Different risk factors of microangiopathy in patients with type 1 diabetes mellitus of short versus long duration. The EURODIAB IDDM Complications Study.Diabetologia 2000; 43: 348-355.

· A. E. Buyken, M. Toeller, G. Heitkamp, K. ‘Irsiglert, C. Hollert, F. Santeusanio, P. Stehle, J. H. Fuller and the EURODIAB IDDM Complications Study Group: Carbohydrate sources and glycaemic controlintype 1 diabetes mellitus. Diabetic Medicine 2000; 17: 351-359.

· SS Soedamah-Muthu, H. M. Colhoun, M. R. Taskinen, B. Idzior-Walus, J. H. Fuller, EURODIAB IDDM Complications Study Group. Differences in HDL-cholesterol:apoA-I + apoA-II ratio and apoE phenotype with albuminuric status in type 1 diabetic patients. Diabetologia 2000; 43: 1353-1359.

· N. Chaturvedi, A. K. Sjoelie, M. Porta, S. J. Aldington, J. H. Fuller, M. Songini, E. M. Kohner, The Eurodiab Prospective Complication Study Group. Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes. Diabetes Care 2001; 24 – 2: 284-289.

· A. E. Buyken, M. Toeller, G Heitkamp, B. Karamanos, R. Rottiers, M. Muggeo, J. H. Fuller M.Sondini et ali (the EURODIAB IDDM Complications Study Group).Glycemic index in the diet of European outpatients with type 1 diabetes: relations to glycated hemoglobin and serum lipids. Am J Clin Nutr 2001; 73: 574-81.

· M. B. Mattock, N. Cronint, P. Cavallo-Perin, B. Idzior-Walus, G. Penno, S. Bandinelli, E. Standl, A. Kofinis, J. H. and the Eurodiab IDDM Complications Study Group. Plasma lipids and urinary albumin excretion rate in type 1 diabetes mellitus: the EURODIAB IDDM Complications Study. Diabetic Medicine 2001; 18:59-67.

· M. A. Crook, J. C. Pickup, P. J. Lumb, F. Giorgino, D.J. Webb, J. H. Fuller and the EURODIAB IDDM Complications Study Group. Relationship between plasma sialic acid concentration and microvascular and macrovascular complication in Type 1 diabetes. The EUORIDIAB Complications Study. Diabetes Care 2001; 24:316-322.

· N. Chaturvedi, S. Bandinelli, R. Mangili, G. Penno, R. Rottiers, J. H. Fuller on behalf of the EURODIAB PCS Group. Microalbuminuria in type 1 diabetes: rates, risk factors and glycaemic threshold: The EURODIAB PCS Group. Kidney International 2001;60:219-227.

· N. Chaturvedi, J. H. Fuller, M. R. Taskinen on behalf of the EURODIAB PCS Group. Differing Associations of Lipid and Lipoprotein Disturbances With the Macrovascular and Microvascular Complications of Type 1 dibetes. Diabetes Care 2001;24:2071-2077.

· P. Kempler, S. Tesfaye, N. Chaturvedi, L. K. Stevens, D. J. Webb, S. Eaton, Z. Kerenyi, G. Tamas, J. D. Ward, J. H. Fuller. Blood Pressure Response to Standing in the Diagnosis of Autonomic Neuropaty: The EURODIAB IDDM Complications Study. Arch Physiol Biochem 2001:109:215-222.

· B. Idizor-Walus, M. B. Mattockt, B. Solnica, L Stevens, J. H. Fuller and the EURODIAB IDDM Complications Study Group. Factors associated with plasma lipids and lipoproteins in type 1 diabetes mellitus: the EURODIAB IDDM Complications Study. Diabetic Medicine 2001; 18: 786-796.

· M. Toeller, AE Buyken, G. Heitkamp, G. Cathelineau, B. Ferriss, G. Michel and the EURODIAB IDDM Complications Study Group. Nutrient intakes as predictors of body weight in European people with type 1 diabetes. International journal of Obesity 2001; 25: 1815-1822.

· M. Porta, A-K. Sjoelie, N. Chaturvedi, L. Stevens, R. Rottiers, M. Veglio, J. H. Fuller and the EURODIAB Prospective Complications Study Group. Risk factors for progression to proliferative diabetic retinopathy in the EURODIAB Prospective Complications Study. Diabetologia 2001; 44: 2203-2209.

· M. Veglio, S. Giunti, L. K. Stevens, J.H. Fuller, P. C. Perin on behalf The EURODIAB IDDM Complications Study. Prevalence of Q-T Interval Dispersion in Type 1 Diabetes and its Relation With Cardiac Ischemia: The EURODIAB IDDM Complications Study. Diabetes Care 2002;25:702-707.

· The Eurodiab IDDM Complications Study Group. Prevalence of Q-T Interval Dispersion in Type 1 Diabetes and Its Relation with Cardiac Ischemia. Diabetes Care 2002 ; 25: 702-707.

· S. S. Soedamah-Muthu, H. M. Colhoun, H. Abrahamian, N. N. Chan, R. Mangili, G. P. Reboldi, J. H. Fuller, the EURODIAB Prospective Complications Study Group. Trends in hypertensionmanagement in type I diabetes across Europe, 1989/1990-1997/1999. Diabetologia 2002; 45: 1362-1371.

· The Eurodiab Prospective Complications Study. Circulating and Urinary Transforming Growth Factor ß1, Amadori Albumin, and Complications of type 1 Diabetes. Diabetes Care 2002; 25: 2320-2327.

· P. Kempler, S. Tesfaye, N. Chaturvedit, L. K. Stevenst, D. J. Webbt,S. Eaton, Zs.Kerènyi, Gy. Tamàs, J. D. Ward, J. H. Fullert and the EURODIAB IDDM Complications Study Groups. Autonomic neuropathy is associated with increased cardiovascular risk factors: the EURODIAB IDDM Complications Study. Diabetic Medicine 2002; 19: 900-909.

· N. Chaturvedi, C. D. A. Stehouwer, C: G: Schalkwijk, H. Abrahamian, J. H. Fuller, The EURODIAB Prospective Complications Study Group. Circulating and Urinary transforming growth factor B1, amadori albumin, and complications of type 1 diabetes. Diabetes Care 2002;25:12:2320-2327.

· The Eurodiab Prospective Complications Study. Vascular Risk Factors and Markers of Endothelial Function as Determinants of Inflammatory Markers inType 1 Diabetes. Diabetes Care 2003;26(7):2165-2173.

 

Contatti segreteria

Sig.ra Monica Porceddu
E-Mail : asris@tin.it
Fax: 070 - 531947

Dove siamo

S.C. di Diabetologia
Azienda Ospedaliera Brotzu
Via Peretti 2 - 09134 - Cagliari

Donazioni

ASRIS – Onlus
Cc Bancario n. 003919431
ABI 02008
CAB 04814
Presso Banca Unicredit – Dip. Cagliari SD Sole

Scroll to top